Loading…
ICON Public Limited Company is projected to rise to $131.01 by 2027, a +11% move from its current price of $118.45. ICLR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $115.31 | $118.49 | $121.75 | +0.03% |
| May 30 | $114.06 | $118.52 | $123.16 | +0.06% |
| May 31 | $113.11 | $118.56 | $124.27 | +0.09% |
| Jun 1 | $112.33 | $118.60 | $125.22 | +0.12% |
| Jun 2 | $111.64 | $118.63 | $126.06 | +0.16% |
| Jun 3 | $111.03 | $118.67 | $126.83 | +0.19% |
| Jun 4 | $110.48 | $118.71 | $127.55 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $110.48 | $118.71 | $127.55 | +0.22% |
| Week 2 | $107.47 | $118.97 | $131.69 | +0.44% |
| Week 3 | $105.27 | $119.23 | $135.02 | +0.65% |
| Week 4 | $103.49 | $119.48 | $137.95 | +0.87% |
| Week 5 | $101.97 | $119.74 | $140.61 | +1.09% |
| Week 6 | $100.64 | $120.01 | $143.10 | +1.31% |
| Week 7 | $99.45 | $120.27 | $145.45 | +1.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ICON Public Limited Company is a healthcare company that operates as a clinical research organization. It provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. ICON serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. It has a strategic alliance with Advarra, Inc.
for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ICON Public Limited Company (ICLR) is a healthcare stock with a current price of $116.78 and a market capitalization of $9.08B. It ranks 969 by market capitalization among peers. The current price aligns with a 2026 forecasted average of $116.78, which carries an implied neutrality with a 0% expected return.
The five-year to multi-decade outlook shows a path of rising averages and expanding ROIs, with bullish momentum emerging in subsequent years and culminating in substantial upside by 2050 (avg $609.50, ROI 421.9%). The forecast also shows a wide 2026 range from $80.08 to $150.40, illustrating variance in near-term projections.
A major floor 32.4% below — a decisive break under it would weaken the trend.
The nearest floor, 13.7% below — buyers have tended to step in here.
The nearest ceiling, 5.5% above — a clean break opens room to run.
A major ceiling 58.7% above — clearing it would confirm fresh momentum.
Key ICLR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICLR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $116.15 | Buy | $116.40 | Buy |
| MA 10 | $115.89 | Buy | $116.44 | Buy |
| MA 20 | $117.70 | Buy | $115.99 | Buy |
| MA 50 | $111.43 | Buy | $116.62 | Buy |
| MA 100 | $127.86 | Sell | $126.26 | Sell |
| MA 200 | $152.09 | Sell | $143.27 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.25 | Neutral |
| Stoch RSI (14) | 43.14 | Neutral |
| CCI (20) | 16.05 | Neutral |
| Williams %R (14) | -57.21 | Info |
| MACD (12,26,9) | -0.43 | Sell |
| ROC (12) | -4.85 | Sell |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 42.79 | Neutral |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | 1.30 | Buy |
| Ultimate (7,14,28) | 51.79 | Neutral |
| Momentum (10) | -3.49 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 116.48 | Buy |
| ADX (14) | 10.14 | Neutral |
| ATR (14) | 2.66 | Info |
The near-term technical picture is neutral. RSI14 is 50, and the price action is in a balanced zone without clear overbought or oversold signals. The stock trades around the 50-day moving average of $110.70, below the 200-day moving average of $152.51, and sits above the near-term support at $102.17 while facing a resistance at $125.00.
The 30-day price range is $97.71 to $139.57, indicating a broad trading band and potential for moves within that corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $80.08 | $118.45 | $153.37 | 0% | Neutral | |
| $103.96 | $131.01 | $174.87 | +11% | Neutral | |
| $123.04 | $159.29 | $220.30 | +34% | Bullish | |
| $136.45 | $180.68 | $257.02 | +53% | Bullish | |
| $133.01 | $179.70 | $261.76 | +52% | Bullish | |
| $142.80 | $196.48 | $292.24 | +66% | Bullish | |
| $143.97 | $201.50 | $305.37 | +70% | Bullish | |
| $140.27 | $199.50 | $307.52 | +68% | Bullish | |
| $176.90 | $255.46 | $399.99 | +116% | Bullish | |
| $193.78 | $283.95 | $451.12 | +140% | Bullish | |
| $247.99 | $388.29 | $655.73 | +228% | Bullish | |
| $362.88 | $636.95 | $1,176.05 | +438% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $80.08 | $118.45 | $138.83 | +0.00% |
| June 2026 | $100.61 | $118.14 | $142.02 | -0.26% |
| July 2026 | $102.91 | $121.85 | $148.45 | +3.14% |
| August 2026 | $102.60 | $122.29 | $150.52 | +0.36% |
| September 2026 | $99.01 | $118.65 | $147.27 | -2.98% |
| October 2026 | $98.80 | $118.99 | $148.81 | +0.28% |
| November 2026 | $100.99 | $122.16 | $153.79 | +2.67% |
| December 2026 | $99.67 | $121.06 | $153.37 | -0.90% |
Click any year to see its month-by-month ICLR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ICLR is projected to trade between $80.08 and $153.37, averaging $118.45 — a potential gain of 0% from today's $118.45. A consolidation phase looks the most probable path here.
ICON Public Limited Company's 2027 outlook centres on $131.01, within a $103.96 to $174.87 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, ICLR could reach as high as $220.30, with a base case around $159.29 and support toward $123.04 — roughly +34% from $118.45. Buyers look set to stay in control over this stretch.
Expect ICLR to range from $136.45 to $257.02 through 2029. The $180.68 average target implies a +53% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The ICLR price prediction for 2030 points to an average of $179.70 (low $133.01, high $261.76) — a potential gain of +52% on today's $118.45. Buyers look set to stay in control over this stretch.
In 2031, ICLR is projected to trade between $142.80 and $292.24, averaging $196.48 — a potential gain of +66% from today's $118.45. That is up +9% on the projected 2030 average. Momentum favours further upside here.
ICON Public Limited Company's 2032 outlook centres on $201.50, within a $143.97 to $305.37 range. That is up +3% on the projected 2031 average. That marks a +70% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ICLR could reach as high as $307.52, with a base case around $199.50 and support toward $140.27 — roughly +68% from $118.45. Momentum favours further upside here.
Expect ICLR to range from $176.90 to $399.99 through 2034. The $255.46 average target implies a +116% move from current prices. That is up +28% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ICLR price prediction for 2035 points to an average of $283.95 (low $193.78, high $451.12) — a potential gain of +140% on today's $118.45. Momentum favours further upside here.
In 2040, ICLR is projected to trade between $247.99 and $655.73, averaging $388.29 — a potential gain of +228% from today's $118.45. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
ICON Public Limited Company's 2050 outlook centres on $636.95, within a $362.88 to $1,176.05 range. That is up +64% on the projected 2040 average. That marks a +438% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ICLR today (≈ 8.442381 ICLR) could be worth
$5,377.41
+$4,377.41 (+438%) by 2050 · US Dollar
Based on the average projected ICLR price of $636.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICLRwould be worth at today's price.
$1,000 invested in ICLR on May 27, 2025 (≈ 7.611508 ICLR) would be worth
$901.58
-$98.42 (-9.8%) today · 0.90× · US Dollar
Based on a ICLR entry price of $131.38 vs. today's $118.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $115.09 | $1,029.19 | +2.9% |
| 1 month ago | $103.21 | $1,147.66 | +14.8% |
| 3 months ago | $106.13 | $1,116.08 | +11.6% |
| 6 months ago | $185 | $640.27 | -36.0% |
| 1 year ago | $131.38 | $901.58 | -9.8% |
| All time (5.0y) ago | $222.76 | $531.74 | -46.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICLR forecast.
Our base-case forecast reaches $240.00 around 2034.
Implied market cap at $240.00: $18.33B
The multi-year forecast shows a bullish trajectory after 2026, with the 2026 average price at $116.78 (ROI 0) and sentiment Neutral. From 2027 onward, the average price climbs to $129.34, then to $155.93 in 2028, $175.54 in 2029, and $176.26 in 2030, with ROIs rising to 50.9% by 2030. The subsequent years remain bullish, with 2031 at $191.66 (ROI 64.1%), 2032 at $194.77 (ROI 66.8%), and 2033 at $194.28 (ROI 66.4%).
The forecast accelerates further in 2034 to $248.17 (ROI 112.5%), and 2035 to $274.19 (ROI 134.8%). By 2040, the average price is projected at $374.56 (ROI 220.7%), and by 2050 at $609.50 (ROI 421.9%), with a max of $1,123.72. These figures imply a sustained bullish outlook over the long term, though they are estimates and carry inherent uncertainty.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $176.26 with a max of $256.62 and a min of $130.53, and an ROI of 50.9%, with bullish sentiment.
Forecasts show a bullish trajectory beyond 2026, with the 2030 average of $176.26 and ROI of 50.9%, rising further to $374.56 in 2040 (ROI 220.7%) and $609.50 in 2050 (ROI 421.9%), indicating potential upside over the long term, albeit with uncertainty.
Yes, the forecast max values show up to $299.23 in 2033, which is just under $300.
The current price is $116.78 and the market cap is $9.08B.
For 2040, the average is $374.56 with an ROI of 220.7%. For 2050, the average is $609.50 with an ROI of 421.9%.
ICON Public Limited Company Community Discussion
0Share your ICON Public Limited Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.